Comprehensive Analysis of Pharmaceutical Development Trends [Vol. 5: Midsize international companies]
Outline of the report
Highlights:
- A total of 24 (26 before mergers) mid-size pharmaceutical companies ranking between 13th and 53th in terms of world pharma sales are profiled.
- You can get answers to the questions including: "Where are they located?", "What type of company are they?", "How close are they related to Japan?", "What are their R&D focus?", "Their profiles before M&A", and so forth.
Companies profiled in this report include the ones whose strengths are in biologic drugs, which license excellent drugs to their Japanese counterparts, which are emerging generic drug manufacturers, which are actively seeking their unique business opportunities while being under the control of a megapharmaceutical company, and which have no Japanese arm.
| Title of the report | Comprehensive Analysis of Pharmaceutical Development Trends [Vol. 5: Midsize international companies] |
| Date of issue | 14/03/08 |
| Volume | A4 / 288 pages |
| Price | 95,000JPY |
| Produced by | Seed Planning, Inc. |
| Note | This report is written in Japanese. Customers who need an English version:Please contact us. |
| Category | Pharmaceutical products / compaines |
Details of the report
Contents
- Cross Analysis / Tabulation
- Company name / address / URL
- Financial data:
Sales / EBITA / Net income / Total assets / R&D cost / headcount - Year-over-year changes in revenues (2003-2006)
- Year-over-year changes in revenues from pharmaceuticals (2003-2006)
- Sales of major products
- Sales by segment
- Sales by region
- R&D cost (headcount / R&D cost / research field)
- Positioning of Japanese arm
- Positioning of Japanese arm among their group worldwide
- Characteristics and recent trends of the companies profiled
- Case study
